CVC and GTCR Make Joint Bid for Teleflex
Private equity firms CVC Capital Partners and GTCR have made a joint proposal to acquire medical device manufacturer Teleflex and take the company private, according to a report by Reuters citing an unnamed source, as reported by Private Equity Wire. The bid is currently under review by Teleflex, with discussions remaining preliminary and no certainty that a transaction will proceed, as the source added that Teleflex could decline the offer or attract competing bids.
Teleflex’s Recent Developments
Teleflex develops and supplies medical technologies such as catheters, breathing tubes, and vascular access products for critical care environments. In December, Teleflex completed the divestment of three business units for approximately $2.03bn as part of its strategic repositioning. Additionally, activist investor Irenic Capital Management criticized Teleflex’s board in March for not engaging more actively with potential strategic alternatives, including a possible sale.
Market Reaction and Firm Backgrounds
Following news of the approach, Teleflex shares rose 13.4% in after-hours trading after a 5.5% decline during the regular session, resulting in a market capitalization of around $5.5bn. CVC, listed in Amsterdam, manages approximately €205bn in assets across private markets, while GTCR, based in Chicago, has an established track record investing in healthcare services and medical technology businesses, according to Private Equity Wire. As is widely known, private equity firms often pursue such acquisitions to restructure companies, though neither CVC, GTCR, nor Teleflex responded to requests for comment.
Implications for the Sector
A successful transaction would align with Teleflex’s ongoing transformation efforts. Prior reporting indicated that CVC and GTCR were exploring a potential acquisition, highlighting ongoing interest in the medical technology space, as noted in the source material.
